Hot News: Nokia Corporation (ADR) (NYSE:NOK), STMicroelectronics NV (NYSE:STM), Radware Ltd. (NASDAQ:RDWR), Inuvo, Inc. (NYSEMKT:INUV), Biota Pharmaceuticals, Inc. (NASDAQ:BOTA)

Microsoft has already made it clear that it’s planning to phase out the Nokia Corporation (ADR) (NYSE:NOK) name in its mobile products, and a newly leaked internal document confirms just that. The document, which was obtained by tech blog GeeksOnGadgets, reportedly says upcoming Nokia Lumia devices will soon be branded as just “Lumia.” Nokia Corporation (ADR) (NYSE:NOK) belongs to Technology sector. Its net profit margin … Continue reading Hot News: Nokia Corporation (ADR) (NYSE:NOK), STMicroelectronics NV (NYSE:STM), Radware Ltd. (NASDAQ:RDWR), Inuvo, Inc. (NYSEMKT:INUV), Biota Pharmaceuticals, Inc. (NASDAQ:BOTA)

Healthcare Insider Buying: Opko Health (NYSE:OPK), American Apparel (NYSEMKT:APP), Accelerate Diagnostics Inc (NASDAQ:AXDX), Biota Pharmaceuticals Inc (NASDAQ:BOTA), Echo Therapeutics Inc (NASDAQ:ECTE)

Opko Health (NYSE:OPK) CEO Phillip Md Et Al Frost purchased 30,000 shares of the stock in a transaction dated Tuesday, July 8th. The shares were purchased at an average price of $8.58 per share, for a total transaction of $257,400.00. Following the completion of the transaction, the chief executive officer now directly owns 1,987,500 shares in the company, valued at approximately $17,052,750. Opko Health Inc. … Continue reading Healthcare Insider Buying: Opko Health (NYSE:OPK), American Apparel (NYSEMKT:APP), Accelerate Diagnostics Inc (NASDAQ:AXDX), Biota Pharmaceuticals Inc (NASDAQ:BOTA), Echo Therapeutics Inc (NASDAQ:ECTE)

Seattle Genetics, Inc (NASDAQ:SGEN) Director Felix Baker purchased 281,963 shares of Seattle Genetics stock in a transaction dated Wednesday, June 4th. The stock was purchased at an average price of $34.86 per share, for a total transaction of $9,829,230.18. Following the transaction, the director now directly owns 76,997 shares of the company’s stock, valued at approximately $2,684,115. Seattle Genetics, Inc. (NASDAQ:SGEN) stock performance was -0.05% … Continue reading Biotech Insider Buying: Seattle Genetics (NASDAQ:SGEN), Corcept Therapeutics Incorporated (NASDAQ:CORT), Cytori Therapeutics (NASDAQ:CYTX), Oramed Pharmaceuticals (NASDAQ:ORMP), Biota Pharmaceuticals (NASDAQ:BOTA)

Miller Energy Resources Inc. (NYSE:MILL) is adding a third rig to its Alaska drilling fleet. Tennessee-based Miller operates in Alaska via its Anchorage-based subsidiary, Cook Inlet Energy LLC. In filings with the U.S. Securities and Exchange Commission, Miller said it had entered into an option to purchase the rig for $3.25 million. The option is with Baker Hughes. Miller Energy Resources Inc (NYSE:MILL) stock performance … Continue reading Micro-cap losers: Miller Energy Resources (NYSE:MILL), Biota Pharmaceuticals (NASDAQ:BOTA), Nova Lifestyle (NASDAQ:NVFY), Agria (NYSE:GRO)

Some days before, shares of Insmed Incorporated (NASDAQ:INSM) fell double digits after the company reported data on a 90 patient Phase 2 trial. Insmed Incorporated (NASDAQ:INSM) stock performance was 7.02% in last session and finished the day at $13.41. Traded volume was 1.55million shares in the last session and the average volume of the stock remained 788.23K shares. The beta of the stock remained 0.69. … Continue reading Biotech gainers: Insmed Incorporated (NASDAQ:INSM), Prothena Corporation (NASDAQ:PRTA), La Jolla Pharmaceutical Company (NASDAQ:LJPC), Biota Pharmaceuticals (NASDAQ:BOTA)

Biota Pharmaceuticals, Inc. (NASDAQ:BOTA) presented an update on the company at the 26th Annual ROTH Conference at 12:30 p.m. PDT, March 11, 2014, at The Ritz-Carlton, Dana Point in California. Biota Pharmaceuticals Inc (NASDAQ:BOTA) stock performance was 10.15% in last session and finished the day at $6.62. Traded volume was 449,674 million shares in the last session and the average volume of the stock remained … Continue reading Healthcare Bullish Stocks: Biota Pharmaceuticals (NASDAQ:BOTA), OncoGenex Pharmaceuticals Inc (NASDAQ:OGXI), Vermillion (NASDAQ:VRML), Genetic Technologies (NASDAQ:GENE)